Public Employees Retirement Association of Colorado’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$607K Hold
5,463
﹤0.01% 928
2026
Q1
$475K Hold
5,463
﹤0.01% 986
2025
Q4
$585K Hold
5,463
﹤0.01% 896
2025
Q3
$552K Hold
5,463
﹤0.01% 925
2025
Q2
$345K Hold
5,463
﹤0.01% 1160
2025
Q1
$289K Hold
5,463
﹤0.01% 1239
2024
Q4
$306K Hold
5,463
﹤0.01% 1274
2024
Q3
$286K Hold
5,463
﹤0.01% 1317
2024
Q2
$224K Sell
5,463
-786
-13% -$31.4K ﹤0.01% 1434
2024
Q1
$271K Sell
6,249
-662
-10% -$29K ﹤0.01% 1366
2023
Q4
$318K Sell
6,911
-777
-10% -$24.5K ﹤0.01% 1298
2023
Q3
$176K Sell
7,688
-297
-4% -$6.65K ﹤0.01% 1575
2023
Q2
$132K Hold
7,985
﹤0.01% 1738
2023
Q1
$142K Buy
+7,985
New +$201K ﹤0.01% 1717

Other funds holding RYTM

Public Employees Retirement Association of Colorado's RYTM Position: Q2 2026 in Review

Public Employees Retirement Association of Colorado held its Rhythm Pharmaceuticals (RYTM) position steady in Q2 2026 at 5,463 shares worth $607K. The position accounts for ﹤0.01% of the portfolio, ranked #928.

Public Employees Retirement Association of Colorado first reported a position in RYTM in Q1 2023 and has held it in 14 quarters since. 302 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Public Employees Retirement Association of Colorado held 5,463 shares of Rhythm Pharmaceuticals worth $607K as of Q2 2026.
  • Public Employees Retirement Association of Colorado left its Rhythm Pharmaceuticals share count unchanged in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Public Employees Retirement Association of Colorado's portfolio in Q2 2026, its #928 holding.
  • Public Employees Retirement Association of Colorado first reported a position in Rhythm Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • 302 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q2 2026, filed 11 Aug 2026.